13/01/2020
Press release: Sensome raises $9 million B round with equity investment from ASAHI INTECC, The two companies start development program to integrate Sensome’s tissue micro-sensor into Asahi’s world class guidewire.EN FR
SENSITIVE MEDICAL DEVICES
OUR TECHNOLOGY
Sensome developed a revolutionary sensor technology that turns invasive medical devices into connected healthcare devices. The company’s sensing technology combines impedance-based micro-sensors with machine learning algorithms to instantly identify biological tissues upon contact with an unequaled predictive reliability. Its first application is the Clotild® connected guidewire for the treatment of ischemic stroke. Sensome's sensor technology can be deployed in multiple other medical fields, such as interventional cardiology and oncology
OUR SMART GUIDEWIRE
OUR TEAM
Our international and interdisciplinary team possesses the skills and know-how to develop high-impact connected medical devices.
AND MENTORS
The team is supported by experienced MedTech entrepreneurs , key opinion leaders in interventional neuroradiology and cardiology, and pioneer scientists from prestigious universities.
FRANZ
CEO
Franz has brought together a world-class team of scientists, engineers and doctors, renowned experts in their respective fields, to help him realize his vision of innovative connected vascular devices. Franz obtained his Ph.D. from Ecole polytechnique on the optimization of drug-eluting stents and is a graduate of the Stanford Ignite-X business program.